Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,026,547 papers from all fields of science
Search
Sign In
Create Free Account
BRL-26921
Known as:
BRL 26921
, BRL26921
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Anistreplase
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1987
1987
High-dose systemic streptokinase and acylated streptokinase-plasminogen complex (BRL 26921) in acute myocardial infarction: alterations of the fibrinolytic system and clearance of fibrinolytic…
M. Köhler
,
P. Hellstern
,
+7 authors
E. Wenzel
Haemostasis
1987
Corpus ID: 46832799
We report the results of two consecutive studies using intravenous bolus injections of streptokinase (SK) or acylated plasminogen…
Expand
Review
1987
Review
1987
Low dose intra-arterial streptokinase and acylated plasminogen-streptokinase activator complex: a retrospective review of two thrombolytic regimes in recent peripheral arterial ischaemia.
J. Earnshaw
,
J. Westby
,
G. Makin
,
B. Hopkinson
European Journal of Vascular Surgery
1987
Corpus ID: 23728056
1986
1986
The systemic fibrinolytic effect of BRL 26921 during the treatment of acute peripheral arterial occlusions.
J. Earnshaw
,
J. Westby
,
G. Makin
,
B. Hopkinson
Thrombosis and Haemostasis
1986
Corpus ID: 26791535
BRL 26921 is a new acylated streptokinase-plasminogen complex which may have a more specific local thrombolytic effect than…
Expand
1985
1985
The use of BRL26921 (APSAC) as fibrinolytic therapy in acute myocardial infarction.
W. Hillis
,
R. Hornung
European Heart Journal
1985
Corpus ID: 19056114
1985
1985
Efficacy of BRL 26921, a new fibrinolytic agent for intravenous infusion, in acute myocardial infarction
F. Rey
,
H. Bonnier
,
H. R. Michels
,
M. Gamal
,
H. Hoffmann
1985
Corpus ID: 58321119
The main goal of therapeutic thrombolysis in acute myocardial infarction is early reperfusion of acutely obstructed coronary…
Expand
1985
1985
Induction of a sustained fibrinolytic response by BRL 26921 in vitro.
R. Fears
,
J. Green
,
R. Smith
,
P. Walker
Thrombosis Research
1985
Corpus ID: 22119032
Highly Cited
1985
Highly Cited
1985
Coronary thrombolysis with intravenous anisoylated plasminogen-streptokinase complex BRL 26921.
M. Been
,
D. D. de Bono
,
A. Muir
,
F. Boulton
,
W. Hillis
,
R. Hornung
British heart journal
1985
Corpus ID: 14305488
BRL 26921 is a protected plasminogen-streptokinase complex with selective affinity for thrombus. When given intravenously within…
Expand
1985
1985
Systemic effects of BRL 26921 during thrombolytic treatment of acute myocardial infarction.
J. Hoffmann
,
F. J. van Rey
,
J. Bonnier
Thrombosis Research
1985
Corpus ID: 33291727
1984
1984
Acylated streptokinase--plasminogen complex in patients with acute myocardial infarction.
I. Walker
,
J. Davidson
,
A. Rae
,
I. Hutton
,
T. Lawrie
Thrombosis and Haemostasis
1984
Corpus ID: 30033471
BRL 26921 is the p- anisoyl derivative of the primary streptokinase-human plasminogen complex in which the acyl group is…
Expand
1981
1981
On the fibrinolytic and thrombolytic properties of active-site p-anisoylated streptokinase-plasminogen complex (BRL 26921).
O. Matsuo
,
D. Collen
,
M. Verstraete
Thrombosis Research
1981
Corpus ID: 67393
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE